Skip to main content

22 October 2025

Last updated: Monday 20 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Commentary: The outlook for biotech seems rosy - for now

Monday 17 February 2014

Interviewee/Contributor

Robin Davison

Organisation

Edison Investment Research Ltd

Financial thermometer rises at JP Morgan meeting

Wednesday 10 February 2010

Interviewee/Contributor

Robin Davison

Organisation

Edison Investment Research

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Organisations

Inception Sciences Inc
Amyl Therapeutics BV
Biotechnology Industry Association BIO
Affibody AB
Independent healthcare analyst
Oxford BioTherapeutics Ltd
Oxford Capital Partners Ltd
Andera Partners
Odlander, Fredrikson and Co AB
European Confederation of Pharmaceutical Entrepreneurs

Interviewees and Contributers

Jackie Turnbull and David Bates
Peter Arlett
David Best
Dr Matthew Wright
Michel Goldman
Justin Duckworth
John Purves
Jérôme Van Biervliet
Simon Ellison
Gerard Brandon

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form